News

The FDA is reviewing clinical trials that send US patients' cells to foreign labs, citing concerns over genetic data security. Learn more about the new regulations.

Researchers have discovered a potential treatment target that may re-energize dysfunctional or “exhausted” immune cells in their fight against cancer. The target is an immune checkpoint called PTGIR.

To reveal the science behind the protein–nanoparticle interaction and its implications for human health, a team of researchers conducted a series of spectroscopy-based experiments.

Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is currently recommended in UK guidelines, finds a new study led by UCL researchers.

A new study shows that patients achieve good outcomes with a partial match drawn from the national public registry of donors when they are treated with the immune-suppressing drug cyclophosphamide.

Two studies unveiled at the 85th Scientific Sessions of the American Diabetes Association in Chicago point to progress in developing stem cell-based treatments for type 1 diabetes.

A new study shows that a vaccine against respiratory syncytial virus is associated with a 29% reduction in dementia risk in the following 18 months. The findings suggest a novel explanation for how vaccines produce this effect.

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized approach to precision medicine could revolutionize how hospitals treat rare diseases, even in low-resource settings.

A pretreatment step could help transplanted pancreatic isle cells survive longer in patients with type 1 diabetes, according to a new preclinical study,

Selumetinib can reduce the pain and size of tumors caused in adults by neurofibromatosis type 1, a rare genetic disease for which there is currently no effective pharmacological treatment.